# Whitehawk Therapeutics, Inc.: filings

WHWK · Nasdaq · CIK 1422142 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/whwk.md) · [Financials](/companies/whwk/financials.md) · [Filings](/companies/whwk/filings.md) · [Insiders](/companies/whwk/insiders.md)

## Reports and events: 237 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 208, 8-K 110, 10-Q 53, 3 33, SC 13D/A 19, 10-K 18, DEFA14A 18, 424B3 17, 144 15, CORRESP 13, SC 13G 12, UPLOAD 12, S-8 11, EFFECT 10, SCHEDULE 13D/A 10, DEF 14A 9, 424B5 8, S-3 8, SC 13D 8, SC 13G/A 7, 4/A 6, SCHEDULE 13G 6, D 5, SCHEDULE 13G/A 5, 8-K/A 4, ARS 4, 5 3, DEFM14A 2, PREM14A 2, S-1/A 2, SCHEDULE 13D 2, 10-K/A 1, 8-A12B 1, CERT 1, CT ORDER 1, DEFM14C 1, POS AM 1, PRE 14A 1, PREM14C 1, S-1 1, S-3/A 1, SC 14F1 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-10 | 17:02 ET | [8-K](/filings/0001193125-26-388010.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-388010 |
| 2026-08-06 | 16:03 ET | [10-Q](/filings/0001193125-26-337933.md) | Quarterly report, period 2026-06-30 | 0001193125-26-337933 |
| 2026-08-06 | 10:08 ET | [8-K](/filings/0001193125-26-337069.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-337069 |
| 2026-06-12 | 16:19 ET | [8-K](/filings/0001193125-26-269493.md) | 5.07 Shareholder vote results | 0001193125-26-269493 |
| 2026-05-21 | 17:16 ET | [8-K](/filings/0001193125-26-234890.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-234890 |
| 2026-05-18 | 19:03 ET | [SCHEDULE 13D/A](/filings/0000935836-26-000289.md) | Ownership report, active investor, amended | 0000935836-26-000289 |
| 2026-05-14 | 20:04 ET | [SCHEDULE 13D/A](/filings/0000902664-26-002450.md) | Ownership report, active investor, amended | 0000902664-26-002450 |
| 2026-05-13 | 08:08 ET | [8-K](/filings/0001193125-26-220656.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-220656 |
| 2026-05-07 | 16:25 ET | [10-Q](/filings/0001193125-26-212075.md) | Quarterly report, period 2026-03-31 | 0001193125-26-212075 |
| 2026-05-07 | 09:12 ET | [8-K](/filings/0001193125-26-210615.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-210615 |
| 2026-04-28 | 16:19 ET | [DEF 14A](/filings/0001193125-26-187149.md) | Proxy statement, period 2026-04-28 | 0001193125-26-187149 |
| 2026-03-12 | 16:12 ET | [10-K](/filings/0001193125-26-104158.md) | Annual report, period 2025-12-31 | 0001193125-26-104158 |
| 2026-03-12 | 08:02 ET | [8-K](/filings/0001193125-26-103117.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-103117 |
| 2025-11-06 | 13:50 ET | [10-Q](/filings/0001193125-25-268895.md) | Quarterly report, period 2025-09-30 | 0001193125-25-268895 |
| 2025-11-06 | 08:03 ET | [8-K](/filings/0001193125-25-268134.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-268134 |
| 2025-08-07 | 16:25 ET | [10-Q](/filings/0000950170-25-105081.md) | Quarterly report, period 2025-06-30 | 0000950170-25-105081 |
| 2025-08-07 | 08:03 ET | [8-K](/filings/0000950170-25-104592.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-104592 |
| 2025-06-13 | 16:39 ET | [8-K](/filings/0001193125-25-140810.md) | 5.07 Shareholder vote results | 0001193125-25-140810 |
| 2025-05-08 | 17:28 ET | [10-Q](/filings/0001628280-25-023932.md) | Quarterly report, period 2025-03-31 | 0001628280-25-023932 |
| 2025-05-08 | 16:09 ET | [8-K](/filings/0001628280-25-023788.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-023788 |
| 2025-04-28 | 16:32 ET | [DEF 14A](/filings/0001628280-25-020311.md) | Proxy statement, period 2025-06-11 | 0001628280-25-020311 |
| 2025-03-31 | 16:57 ET | [8-K/A](/filings/0001193125-25-068845.md) | 9.01 Financial statements and exhibits | 0001193125-25-068845 |
| 2025-03-28 | 17:47 ET | [10-K](/filings/0001628280-25-015269.md) | Annual report, period 2024-12-31 | 0001628280-25-015269 |
| 2025-03-26 | 08:21 ET | [8-K](/filings/0001193125-25-063253.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001193125-25-063253 |
| 2025-03-18 | 16:38 ET | [8-K](/filings/0001193125-25-056708.md) | 2.02 Results of operations; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-25-056708 |
| 2025-03-06 | 17:55 ET | [SCHEDULE 13D/A](/filings/0000950170-25-034969.md) | Ownership report, active investor, amended | 0000950170-25-034969 |
| 2025-03-05 | 15:58 ET | [SCHEDULE 13D/A](/filings/0001373604-25-000045.md) | Ownership report, active investor, amended | 0001373604-25-000045 |
| 2025-03-04 | 17:58 ET | [SCHEDULE 13D/A](/filings/0000902664-25-001335.md) | Ownership report, active investor, amended | 0000902664-25-001335 |
| 2025-03-04 | 16:16 ET | [8-K](/filings/0001193125-25-045605.md) | 1.01 Entry into a material agreement; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-045605 |
| 2025-02-24 | 11:38 ET | [SCHEDULE 13D/A](/filings/0001373604-25-000038.md) | Ownership report, active investor, amended | 0001373604-25-000038 |
| 2025-02-04 | 11:11 ET | [SCHEDULE 13D/A](/filings/0001373604-25-000005.md) | Ownership report, active investor, amended | 0001373604-25-000005 |
| 2025-01-30 | 15:32 ET | [SCHEDULE 13D](/filings/0001373604-25-000003.md) | Ownership report, active investor | 0001373604-25-000003 |
| 2025-01-24 | 14:34 ET | [SCHEDULE 13D/A](/filings/0000935836-25-000082.md) | Ownership report, active investor, amended | 0000935836-25-000082 |
| 2024-12-31 | 11:13 ET | [SCHEDULE 13D](/filings/0001373604-24-000118.md) | Ownership report, active investor | 0001373604-24-000118 |
| 2024-12-23 | 17:26 ET | [SCHEDULE 13D/A](/filings/0000950170-24-139724.md) | Ownership report, active investor, amended | 0000950170-24-139724 |
| 2024-12-23 | 15:51 ET | [SCHEDULE 13D/A](/filings/0000902664-24-007000.md) | Ownership report, active investor, amended | 0000902664-24-007000 |
| 2024-12-20 | 06:05 ET | [8-K](/filings/0001193125-24-282407.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-282407 |
| 2024-11-06 | 16:08 ET | [10-Q](/filings/0001628280-24-045698.md) | Quarterly report, period 2024-09-30 | 0001628280-24-045698 |
| 2024-11-06 | 08:05 ET | [8-K](/filings/0001628280-24-045465.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-045465 |
| 2024-10-01 | 17:35 ET | [SC 13D/A](/filings/0001193125-24-230376.md) | Ownership report, active investor, amended | 0001193125-24-230376 |
| 2024-09-30 | 06:06 ET | [8-K](/filings/0001193125-24-228322.md) | 8.01 Other events | 0001193125-24-228322 |
| 2024-09-19 | 16:13 ET | [8-K](/filings/0001193125-24-222116.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-222116 |
| 2024-08-22 | 16:15 ET | [8-K](/filings/0001193125-24-205370.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-205370 |
| 2024-08-21 | 21:21 ET | [8-K](/filings/0001193125-24-203889.md) | 2.05 Exit or disposal costs; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-203889 |
| 2024-08-07 | 16:16 ET | [10-Q](/filings/0001628280-24-035636.md) | Quarterly report, period 2024-06-30 | 0001628280-24-035636 |
| 2024-08-07 | 08:02 ET | [8-K](/filings/0001628280-24-035390.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-035390 |
| 2024-06-12 | 16:18 ET | [8-K](/filings/0001628280-24-027826.md) | 5.07 Shareholder vote results | 0001628280-24-027826 |
| 2024-05-08 | 16:05 ET | [10-Q](/filings/0001628280-24-021657.md) | Quarterly report, period 2024-03-31 | 0001628280-24-021657 |
| 2024-05-08 | 08:07 ET | [8-K](/filings/0001628280-24-021381.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-021381 |
| 2024-04-26 | 14:31 ET | [DEF 14A](/filings/0001628280-24-018546.md) | Proxy statement, period 2024-06-11 | 0001628280-24-018546 |

Page 1 of 5. [Older](/companies/whwk/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.